| 757668 |
FRONTIERS IN ONCOLOGY |
Research Progress on Circular RNA in Glioma |
2021-10-21 |
10.3389/fonc.2021.705059 |
Chen Mengyu, Yan Chunyan, Zhao Xihe |
| 757667 |
FRONTIERS IN ONCOLOGY |
Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation |
2021-10-21 |
10.3389/fonc.2021.745590 |
Zou Dan, Bai Jin, Lu Enting, Yang Chunjiao, Liu Jiaqing, Wen Zhenpeng, Liu Xuqin, Jin Zi, Xu Mengdan, Jiang Lei, Zhang Ye, Zhang Yi |
| 757666 |
FRONTIERS IN ONCOLOGY |
The Oncology Safety of Diagnostic Hysteroscopy in Early-Stage Endometrial Cancer: A Systematic Review and Meta-Analysis |
2021-10-21 |
10.3389/fonc.2021.742761 |
Du Yi, Xu Yu, Qin Zhaojuan, Sun Liang, Chen Yali, Han Ling, Zheng Ai |
| 757665 |
FRONTIERS IN ONCOLOGY |
Which Clinicopathologic Parameters Suggest Primary Resistance to Palbociclib in Combination With Letrozole as the First-Line Treatment for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer? |
2021-10-21 |
10.3389/fonc.2021.759150 |
Kim Ji-Yeon, Oh Jung Min, Park Yeon Hee, Ahn Jin Seok, Im Young-Hyuck |
| 757664 |
FRONTIERS IN ONCOLOGY |
Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers |
2021-10-21 |
10.3389/fonc.2021.757323 |
Cargill Kasey R., Hasken William L., Gay Carl M., Byers Lauren A. |
| 757663 |
FRONTIERS IN ONCOLOGY |
A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer |
2021-10-21 |
10.3389/fonc.2021.690336 |
Zhu Meizhen, Liang Chenlu, Zhang Fanrong, Zhu Liang, Chen Daobao |
| 757662 |
FRONTIERS IN ONCOLOGY |
Cause of Death in Patients in Radiation Oncology |
2021-10-21 |
10.3389/fonc.2021.763629 |
Domschikowski Justus, Koch Karoline, Schmalz Claudia |
| 757661 |
FRONTIERS IN ONCOLOGY |
LncRNA PPM1A-AS Regulate Tumor Development Through Multiple Signal Pathways in T-Cell Acute Lymphoblastic Leukemia |
2021-10-21 |
10.3389/fonc.2021.761205 |
Li Guoli, Lei Xinyue, Zhang Yingchi, Liu Zhe, Zhu Kegan |
| 757660 |
FRONTIERS IN ONCOLOGY |
A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE |
2021-10-21 |
10.3389/fonc.2021.742630 |
Hu Shuyang, Gan Wei, Qiao Liang, Ye Cheng, Wu Demin, Liao Boyi, Yang Xiaoyu, Jiang Xiaoqing |
| 757659 |
FRONTIERS IN ONCOLOGY |
The Significance of SIX1 as a Prognostic Biomarker for Survival Outcome in Various Cancer Patients: A Systematic Review and Meta-Analysis |
2021-10-21 |
10.3389/fonc.2021.622331 |
Zhu Guang, Liu Ying, Zhao Lei, Lin Zhenhua, Piao Yingshi |
